Synthesis history

Anthropic entered the thread as a new voice with its AI for Science rare disease grant program, adding a beneficial-acceleration framing that complements but is distinct from DeepMind's dual-use/bioresilience positionin…

AI is reshaping biological research through two converging developments: a computational shift in how science is done, and a dual-use risk that the same tools accelerating drug discovery could lower barriers to biologic…